vTv Therapeutics Inc. Class A (VTVT) Dividend History

vTv Therapeutics Inc. Class A (VTVT) is a biopharmaceutical company focused on developing therapies for neurodegenerative diseases and diabetes. The company leverages proprietary technologies to pioneer novel treatment options, with an emphasis on improving patient outcomes in chronic and traditionally underserved conditions.

3980 Premier Dr, High Point, NC, 27265
Phone: 336-841-0300
Website: https://www.vtvtherapeutics.com

Dividend History

vTv Therapeutics Inc. Class A currently does not pay dividends

Company News

  • vTv Therapeutics has appointed Michael Tung as its new Chief Financial Officer. The company has also reinitiated screening in its CATT1 Phase 3 trial for cadisegliatin, a potential first-in-class oral adjunctive therapy to insulin for the treatment of type 1 diabetes.

    GlobeNewswire Inc.
  • U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The S&P 500 also fell, dropping, 0.18% to 5,068.92. Check This Out: Robinhood, Shake Shack And 2 Other Stocks Insiders Are Selling   Leading and Lagging Sectors   Real estate shares rose by 1.4% on Wednesday. In trading on Wednesday, communication services shares fell by 0.8%.   Top Headline   ADT Inc. (NYSE: ADT) reported better-than-expected earnings for its fourth quarter on Wednesday. ADT posted fourth-quarter fiscal 2023 sales decline of 7.2% year-on-year to $1.22 billion, missing the consensus of $1.44 billion. Adjusted EPS was 25 cents, beating the consensus of 4 cents. ADT expects CSB segment revenue of 4.8 billion-$5.0 billion. The company expects adjusted EPS of $0.60 – $0.70, against consensus of $0.50.   Equities Trading UP   Vivani Medical, Inc. (NASDAQ: VANI) shares shot up 274% to $3.78 after the company announced preclinical data on weight loss effects for NPM-115 and disclosed that semaglutide is the active pharmaceutical ingredient in NPM-139. Shares of Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) got a boost, surging 159% to $2.1917. ...

    Benzinga
    Featured Companies: ADIL ADT IAS INGN OGEN VANI
  • Penny stocks under $1 to watch this week. The post 7 Hot Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: AKBA MYO
  • vTv Therapeutics (VTVT) delivered earnings and revenue surprises of 0% and 100%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
Page data last updated 07/22/2025 19:59:54 UTC